Skip to main content
. 2021 Apr 20;11:665420. doi: 10.3389/fonc.2021.665420

Figure 8.

Figure 8

Activated mTOR signaling induces the secretion of IL-4 in melanomas and YM1 in macrophages in the tumor microenvironment. Secreted YM-1enhances the EEA1-mediated xCT capture via the KEAP1/NRF2 signaling pathway to promote antioxidant mechanisms through GSH in radiotherapy. Therefore, the regulation of mTOR activity using rapamycin could increase tumor sensitivity to γ-radiation-induced ROS by inhibiting the interaction between melanoma and macrophages.